Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fenofibrate to Prevent Ischemic Cholangiopathy in Donation After Circulatory Death Liver Transplantation (FICsDCD)

NCT05514119 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05514119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05514119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fenofibrate to Prevent Ischemic Cholangiopathy in Donation After Circulatory Death Liver Transplantation (FICsDCD)
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Terminated
Start date
August 17, 2022
Completion date
December 1, 2024
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplant